Clinical trials
Trials in Slovakia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Comenius University | 7 |
| Pavol Jozef Safarik University | 5 |
| Slovak Academy of Sciences | 4 |
| EPC Education s.r.o. | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Premedix Academy | 3 |
| University Hospital, Martin | 3 |
| F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | 2 |
| Intec Pharma Ltd. | 2 |
| Australasian Gastro-Intestinal Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 3 |
| Rectal Neoplasms | 3 |
| Back Pain | 2 |
| COVID-19 | 2 |
| Coronary Artery Disease | 2 |
| Hepatitis, Alcoholic | 2 |
| Ischemic Stroke | 2 |
| Neoplasms | 2 |
| Obesity | 2 |
| Parkinson Disease | 2 |
Trials
Showing 76 to 59 of 59. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.